Cohen, C.F.; Roh, J.; Lee, S.H.; Park, C.-K.; Berta, T. Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine. Int. J. Mol. Sci.2023, 24, 7897.
Cohen, C.F.; Roh, J.; Lee, S.H.; Park, C.-K.; Berta, T. Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine. Int. J. Mol. Sci. 2023, 24, 7897.
Cohen, C.F.; Roh, J.; Lee, S.H.; Park, C.-K.; Berta, T. Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine. Int. J. Mol. Sci.2023, 24, 7897.
Cohen, C.F.; Roh, J.; Lee, S.H.; Park, C.-K.; Berta, T. Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine. Int. J. Mol. Sci. 2023, 24, 7897.
Abstract
Migraine is a neurovascular disorder that affects approximately 12% of the global population. While its exact causes are still being studied, researchers believe that nociceptors in the trigeminal ganglia play a key role in the pain signals of migraine. These nociceptors innervate the intracranial meninges and convey pain signals from the meninges to the thalamus. Targeting these nociceptors is considered promising due to their accessibility and distinct molecular profile, which includes the expression of several transient receptor potential (TRP) channels. These channels have been linked to various pain conditions, including migraine. This review discusses the role and mechanisms of nociceptors in migraine, the challenges of current antimigraine drugs, and the evidence for well-studied and emerging TRP channels, particularly TRPC4, as novel targets for migraine prevention and treatment.
Medicine and Pharmacology, Neuroscience and Neurology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
